Main > CRITICAL/INTENSIVE CARE MEDICINE > USA. E. HypoTension>Alpha- & Beta->
USA. E. HypoTension>Alpha- & Beta->'s subsections
(*) USA Approval Date: 2021. 06.15
(*) USA Launch Date: 2022. 03.14
>Adrenergic Agonist & NorEpinephri>
Company
Company Marketing Partner
Generic Name: ephedrine.HCl
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2022. 03.15
PR Web-Site
RTM
USA. E. HypoTension>Alpha- & Beta->'s products
This section has no products